Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

IMO, most of what you said is simply a long winded rant.

Therefore, I will keep it rather short and to the point:
Quote:

BLOZF has been targeting THC compounds....PERIOD. By refining, refining and more refining the process...BLOZF has become closer and closer to the finish line.

BTHCF keeps changing the direction of target breath compounds.....EACH time BTHCF changes breath target compounds...we go back to square one. Each time BTHCF goes back to square one, while BLOZF keeps refining its breathalyzer....the valuation between the two companies widens...as expected by most people. So...Its simply unreasonable to believe otherwise.

I agree...Cannabix has spent nearly 5 years targeting THC and to date there is zero timeline to completion. Closer and closer to what year? 2020, 2021,2022...please tell me when to stop. No, there is no refining that coorelates to a widening of market values. It's simply one story has been pumped and dumped multiple times over. Currently the sister company is in a dry spell because the story has gotten rather long winded. Breathtec never got a real story out to the masses. Meaning a sustained pump and dump story bankrolled by management.

All things are NOT equal.....BLOZF is in manufacturing and field testing....and therefore...very close to the finish line........meanwhile BTHCF keeps starting over with breath target compounds.

This is where your claims go completely off the rails. BLOZF is not in manufacturing mode nor field testing. Nor would they be close to finish whenever they do start field testing a device. A comparison would be Hound Labs. They have field tested their device for no less than 2 years. I'd bet their device works at least to their claims, because they inked a 25 million dollar distribution deal overseas that got derailed by the Trump administrations foreign policy rhetoric.

https://www.dailysabah.com/business/2018/09/05/turkish-company-unilaterally-terminates-contract-with-us-firm-after-boycott-call

Also, you're going back to the breath compounds again. No - we have multiple Lead Compounds ramping up for Phase II clinical trials that could be worth billions to Big Pharma.

In regards to manufacturing and distribution, if you read/comprehend Algernon's gameplan, the only thing our device requires is the "mechanics" of the device to be refined. Algernon is leaving all the "Compound" (research) issues to the end user (global scientific community). You are simply making things up...AGAIN.

However, shell has stated he believes Algernon is working on a NASH disese breathalyzer. VCurrently there is no written proof of such work, but even if it were, it does not impede distributing our POC RUO device(s). At the point Cannabix is "field testing" devices with the "scientific industry", Cannabix needs to explain why Algernon is not distributing a device to the scientific community (our target market). The Wolves Are Waiting & Watching.

/////AMG

P.S. What I would also state, is the way you come at Algernon leaves one no choice but to air dirty laundry. You claim to own shares of Algernon, but it's my guses those shares aren't many. Hence, the reason why you have done nothing but post negative opposition to some stellar due dilligence posted to this board. I mean one would think we could catch a breather here given that shareholders already got the crap beaten out of them, but obviously you see things differently. Perhaps, similar to how I and the DD Support Board and Fraud Research Team @ ihub see it differently than others @ LIHTF message board.